Faron Pharmaceuticals

Virtual drug company

Synergistics technologies

Drug candidates

Recent news
First Traumakine®-related patent granted for Faron
Faron and Rentschler to co-operate on Traumakine® development
Faron updates pipeline development plans
Faron's extraordinary shareholders' meeting invites Dr. Risto Lammintausta to join Faron Board
More news...

Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:

 

• vasculopathies

• traumas

• inflammation

• metastasis